Selexis SA Announces Participation At Two Upcoming Industry Conferences

GENEVA--(BUSINESS WIRE)--Selexis SA, a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, announced today its planned participation at two industry conferences in the coming weeks, as follows:

- PEGS Europe

31 October 2016 to 4 November 2016, Lisbon, Portugal Selexis Chief Scientific Officer Pierre-Alain Girod, PhD, will present “Engineering of CHO Cell Lines for Enhanced Process Robustness,” on 2 November at 12:30 p.m. GMT. Selexis will also be sponsoring and exhibiting at the conference.

Back to news